PathoFinder Holding B.V., headquartered in the Netherlands, is a pioneering entity in the molecular diagnostics industry. Founded in 2009, the company has established itself as a leader in developing innovative solutions for infectious disease detection, particularly through its advanced multiplex PCR technology. With a focus on enhancing patient care, PathoFinder offers unique products such as the PathoFinder® multiplex assays, which enable rapid and accurate identification of pathogens. This capability sets them apart in a competitive market, catering to hospitals and laboratories across Europe and beyond. Recognised for its commitment to quality and innovation, PathoFinder has achieved significant milestones, including collaborations with leading healthcare institutions. As a result, the company continues to strengthen its market position, contributing to the advancement of diagnostic practices worldwide.
We don't have data for PathoFinder Holding B.V., but we can show you information about their parent organization instead.
View parent company